MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

A new distinct spastic ataxia with hypomyelination: Clinical, neuroimaging and molecular expression of NKX6-2 mutations

V. Chelban, N. Kaya, M. Alsagob, S. Efthymiou, J. Vandrovcova, D. Lynch, K. Kloth, A. Chirita-Emandi, F. Alkuraya, N. Wood, H. Houlden (London, United Kingdom)

Meeting: 2018 International Congress

Abstract Number: 127

Keywords: Ataxia: Genetics, Spasticity: Genetics

Session Information

Date: Saturday, October 6, 2018

Session Title: Genetics (Non-PD)

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To identify the phenotypic, neuroimaging and genotype-phenotype expression of NKX6-2 mutations.

Background: Despite advances in genetic testing a large number of hyopomyelinating disorders remain a genetic mystery. We identified a new distinct phenotype of spastic-ataxia with hyopomyelination negative for previously known hyopomyelinating genes.

Methods: We used a combination of homozygozity mapping, exome sequencing, immunobloting, clinical and neuroimaging for novel gene discovery. Using gene expression and network analysis with Weighed Genes Co-expression we placed the new gene within a regulatory pathway.

Results: We mapped this phenotype to deleterious bi-allellic mutations in NKX6-2 in 14 cases of different ethnic backgrounds providing evidence for a high NKX6-2 mutation burden in hypomyelinating leukodystrophy disease spectrum. We show that the phenotypic and neuroimaging expression in NKX6-2 is mutation-specific and that phenotypes with epilepsy in the absence of overt hypomyelination, as well as diffuse hypomyelination without seizures can occur. Our data suggests that the phenotypic consequences of NKX6-2 mutations is classified in three main subgroups: severe global psychomotor delay with widespread hypomyelination, spastic-ataxia with hypomyelination and spastic-ataxia with seizures.In-silico analysis of human brain expression and network data shows that NKX6-2 is involved in oligodendrocyte maturation and may act within the same pathways of genes already associated with central hypomyelination.

Conclusions: Combining genetic, phenotypic and functional data this study contributes with the discovery of novel NKX6-2 pathogenic mutations and provides new insights into NKX6-2 related disease. Therefore, our case series suggests that NKX6-2 mutations should be considered in patients with autosomal recessive, very early onset of nystagmus, cerebellar ataxia with spasticity particularly when associated with typical neuroimaging signs of hypomyelination.

To cite this abstract in AMA style:

V. Chelban, N. Kaya, M. Alsagob, S. Efthymiou, J. Vandrovcova, D. Lynch, K. Kloth, A. Chirita-Emandi, F. Alkuraya, N. Wood, H. Houlden. A new distinct spastic ataxia with hypomyelination: Clinical, neuroimaging and molecular expression of NKX6-2 mutations [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/a-new-distinct-spastic-ataxia-with-hypomyelination-clinical-neuroimaging-and-molecular-expression-of-nkx6-2-mutations/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/a-new-distinct-spastic-ataxia-with-hypomyelination-clinical-neuroimaging-and-molecular-expression-of-nkx6-2-mutations/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley